Entia Biosciences(OTC) ERGO

Entia Biosciences, Inc. is a healthcare company focused on the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products. The company is known for its innovative product, ErgoD2, which aims to improve iron homeostasis and address iron-related disorders.

Products and Services

• ErgoD2, a pharmaceutical-grade organic compound for iron-related disorders
• Natural formulations for medical food, nutraceuticals, and cosmetics
• Beauty products marketed under the GROH brand name

Growth Outlook

• Increasing demand for dietary supplements and nutraceuticals in the U.S. market
• Expansion of e-commerce channels for direct consumer marketing
• Potential for new product development in the medical food sector

Financial Highlights

• Recent quarterly revenue of 45,986, showing growth potential
• Gross profit margin of 77.99% indicates strong product profitability
• Operating expenses reflect ongoing investment in product development

Entia Biosciences, Inc. operates in a growing sector, with a focus on innovative health solutions. The company’s flagship product, ErgoD2, addresses significant health issues related to iron deficiency, which is prevalent in various populations. The increasing consumer awareness of health and wellness is driving demand for dietary supplements, positioning Entia Biosciences favorably in the market. The company has been actively expanding its e-commerce presence, allowing for direct engagement with consumers. This strategy not only enhances brand visibility but also facilitates a broader reach in the competitive health and wellness market. The potential for new product development, particularly in the medical food sector, further supports the company’s growth trajectory. Financially, the recent quarterly revenue indicates a positive trend, while the gross profit margin suggests that the company is effectively managing its production costs. Although operating expenses are significant, they reflect a commitment to research and development, which is crucial for long-term sustainability and growth. Overall, Entia Biosciences, Inc. presents an intriguing opportunity for investors interested in the healthcare and wellness sectors.